ENHERTU® Approved in the EU for HER2-Low Metastatic Breast Cancer Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) announced the approval of ENHERTU® (trastuzumab deruxtecan) in the European Union (EU)…
eClinical Solutions: AI Adoption and Risk-Based Strategies in 2025 Clinical Trials eClinical Solutions LLC, a global provider of digital clinical software and services, has unveiled key insights from its 2025…
Saskatchewan Expands Public Coverage for Dexcom CGM Systems The Government of Saskatchewan has officially expanded its public coverage for continuous glucose monitoring (CGM) systems, a decision that is set to…
Predictmedix AI Closes $100,000 Third Tranche and Launches Smart Health AI Stations Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP), a leader in AI-powered health screening solutions, is excited…
Siemens Healthineers’ Antithrombin Blood Test FDA Cleared as Companion Diagnostic for Sanofi’s Qfitlia Hemophilia Therapy Siemens Healthineers announced that its Innovance Antithrombin assay has received FDA clearance for a new…
Cell Therapy for Male Urethral Stricture: BEES-HAUS Trial at Edogawa Hospital, Japan Urethral stricture, a condition that affects men across all age groups but becomes more prevalent after the age…
Sphere Bio Launches Cyto-Cellect IgG Kappa and Viability Assay Kit for Single-Cell Selection Sphere Bio, a leader in picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, has unveiled the…
Novotech Secures New Investment from GIC, Temasek, and TPG to Boost Global Growth Novotech, a leading full-service biotech clinical research organization (CRO), announced today that affiliates of GIC and Temasek…
Invivoscribe Registers LeukoStrat® CDx FLT3 Assay in UK & Switzerland Invivoscribe, a global leader in precision diagnostics, has announced the successful registration of its LeukoStrat CDx FLT3 Mutation Assay in…
Bayer Unveils New Heart Failure & Kidney Disease Research at ACC.25 Bayer has announced the presentation of 13 new data analyses from its comprehensive KERENDIA® (finerenone) clinical trial program at…
VantAI Unveils Neo-1: AI Model for Molecular Interaction Design VantAI has unveiled Neo-1, the world’s most advanced atomistic foundation model, marking a significant milestone in molecular design and drug discovery.…
FDA Clears Quibim’s QP-Prostate® CAD for Lesion Detection and Diagnosis Quibim, a global leader in imaging biomarkers for precision medicine, has achieved a significant milestone with the U.S. Food and…